{
  "title": "FDA Approves Aducanumab — A Controversial Drug For Alzheimer's",
  "description": "The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. <a href=\"https://www.npr.org/people/578890280/rhitu-chatterjee\">Rhitu Chatterjee</a> talks with science correspondent <a href=\"https://www.npr.org/people/2100615/jon-hamilton\">Jon Hamilton</a> about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. <br/><br/>For more of Jon's reporting, read \"<a href=\"https://www.npr.org/sections/health-shots/2021/06/15/1006297084/for-those-facing-alzheimers-a-controversial-drug-offers-hope\">For Those Facing Alzheimer's, A Controversial Drug Offers Hope</a>.\"<br/><br/>You can email Short Wave at <a href=\"mailto:shortwave@npr.org\">ShortWave@NPR.org</a>.",
  "pubDate": "Fri, 25 Jun 2021 00:10:15 -0400",
  "copyright": "Copyright 2019-2021 NPR - For Personal Use Only",
  "guid": "f6e6c294-ce19-42cb-9fff-7c464cbc30ca",
  "link": "https://www.npr.org/2021/06/17/1007606381/fda-approves-aducanumab-a-controversial-drug-for-alzheimers",
  "itunes:title": "FDA Approves Aducanumab — A Controversial Drug For Alzheimer's",
  "itunes:episode": 429,
  "itunes:author": "NPR",
  "itunes:summary": "The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical.",
  "itunes:subtitle": "The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical.",
  "itunes:image": "",
  "itunes:duration": 712,
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "content:encoded": "The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. <a href=\"https://www.npr.org/people/578890280/rhitu-chatterjee\">Rhitu Chatterjee</a> talks with science correspondent <a href=\"https://www.npr.org/people/2100615/jon-hamilton\">Jon Hamilton</a> about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. <br/><br/>For more of Jon's reporting, read \"<a href=\"https://www.npr.org/sections/health-shots/2021/06/15/1006297084/for-those-facing-alzheimers-a-controversial-drug-offers-hope\">For Those Facing Alzheimer's, A Controversial Drug Offers Hope</a>.\"<br/><br/>You can email Short Wave at <a href=\"mailto:shortwave@npr.org\">ShortWave@NPR.org</a>.",
  "enclosure": ""
}